In recent decades, monoclonal antibody therapy has proven to be very effective in the treatment of many diseases, such as cancer (especially B lymphomas), chronic inflammatory diseases (multiple sclerosis, rheumatoid arthritis), as well as some diseases of infectious origin, such as: as Covid-19.
- OUR FILE – Cigarette. how to get out of it?
But because this type of immunotherapy relies on the use of antibodies that are difficult to create and produce on a large scale, production costs and treatment prices remain very high. Thus, in rich countries or for wealthy individuals, monoclonal antibodies have become the mainstay of medical care, while in poorer countries or people with limited financial resources, effective monoclonal antibody treatment is simply out of reach. This leads to a great disparity against the disease. Develop new technologies to reduce the cost of antibody production…
Source: Le Figaro
I am John Sinkler, a professional writer and journalist for Buna Times. I specialize in writing about entertainment-related topics and have been doing so for several years now. My work has been featured on multiple platforms and I’m proud to say that it’s gained recognition from many people in the industry. Aside from working at Buna Times, I also write freelance articles for other publications.